TY - JOUR
T1 - Preoperative lymphocyte-monocyte ratio ameliorates the accuracy of differential diagnosis in non-metastatic infiltrative renal masses
AU - Han, Jang Hee
AU - Yoon, Young Eun
AU - Kim, Sook Young
AU - Cho, Young In
AU - Rha, Koon Ho
AU - Choi, Young Deuk
AU - Han, Woong Kyu
N1 - Publisher Copyright:
© Yonsei University College of Medicine 2017.
PY - 2017/3
Y1 - 2017/3
N2 - Purpose: Distinguishing infiltrative renal cell carcinoma (RCC) from transitional cell carcinoma (TCC) is a challenging issue due to their radiologic similarities. We evaluated systemic inflammatory biomarkers as parameters for distinguishing tumor types. Materials and Methods: A computerized search of medical records from November 2005 to October 2015 identified 116 patients with infiltrative renal masses who were difficult to diagnose confirmatively in radiological study. We investigated the diagnostic efficacy among these patients with their preoperative absolute neutrophil counts (ANC), absolute lymphocyte counts (ALC), absolute monocyte counts (AMC), neutrophil-lymphocyte ratio (NLR), and lymphocyte-monocyte ratio (LMR). Results: The infiltrative RCC group demonstrated significantly lower ALC {1449/μL (1140–1896), median [interquartile range (IQR)]} than the TCC group [1860/μL (1433–2342), p=0.016]. LMR [median (IQR)] also was lower in the infiltrative RCC group [2.98 (2.32–4.14) vs. TCC group 4.10 (2.86–6.09); p=0.011]. In subgroup analysis, non-metastatic infiltrative RCC showed lower ALC and LMR and higher NLR than non-metastatic TCC. Within non-metastatic infiltrative renal masses, multivariate logistic regression analysis revealed that younger patient age and lower LMR were associated with infiltrative RCC [odds ratios (OR) 0.874, p=0.024 and OR 0.461, p=0.048, respectively]. Receiver operating characteristic curve analysis showed that younger age and lower LMR were highly predictive of non-metastatic RCC (area under the curve=0.919, p<0.001). Conclusion: Age and LMR were significantly different between patients with infiltrative renal mass. These are potential markers for distinguishing between infiltrative RCC and TCC without metastasis.
AB - Purpose: Distinguishing infiltrative renal cell carcinoma (RCC) from transitional cell carcinoma (TCC) is a challenging issue due to their radiologic similarities. We evaluated systemic inflammatory biomarkers as parameters for distinguishing tumor types. Materials and Methods: A computerized search of medical records from November 2005 to October 2015 identified 116 patients with infiltrative renal masses who were difficult to diagnose confirmatively in radiological study. We investigated the diagnostic efficacy among these patients with their preoperative absolute neutrophil counts (ANC), absolute lymphocyte counts (ALC), absolute monocyte counts (AMC), neutrophil-lymphocyte ratio (NLR), and lymphocyte-monocyte ratio (LMR). Results: The infiltrative RCC group demonstrated significantly lower ALC {1449/μL (1140–1896), median [interquartile range (IQR)]} than the TCC group [1860/μL (1433–2342), p=0.016]. LMR [median (IQR)] also was lower in the infiltrative RCC group [2.98 (2.32–4.14) vs. TCC group 4.10 (2.86–6.09); p=0.011]. In subgroup analysis, non-metastatic infiltrative RCC showed lower ALC and LMR and higher NLR than non-metastatic TCC. Within non-metastatic infiltrative renal masses, multivariate logistic regression analysis revealed that younger patient age and lower LMR were associated with infiltrative RCC [odds ratios (OR) 0.874, p=0.024 and OR 0.461, p=0.048, respectively]. Receiver operating characteristic curve analysis showed that younger age and lower LMR were highly predictive of non-metastatic RCC (area under the curve=0.919, p<0.001). Conclusion: Age and LMR were significantly different between patients with infiltrative renal mass. These are potential markers for distinguishing between infiltrative RCC and TCC without metastasis.
UR - http://www.scopus.com/inward/record.url?scp=85010689133&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85010689133&partnerID=8YFLogxK
U2 - 10.3349/ymj.2017.58.2.388
DO - 10.3349/ymj.2017.58.2.388
M3 - Article
C2 - 28120570
AN - SCOPUS:85010689133
SN - 0513-5796
VL - 58
SP - 388
EP - 394
JO - Yonsei medical journal
JF - Yonsei medical journal
IS - 2
ER -